PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Metopimazine→

Metopimazine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
14008-44-7
Molecular formula
C22H27N3O3S2
Molecular weight
445.6 g/mol
Drug class
Phenothiazine-derived dopamine D2 receptor antagonistantiemetic
Mechanism of action
Blocks dopamine D2 receptors in the chemoreceptor trigger zone and other emetic pathways, reducing nausea and vomiting. It has limited antipsychotic activity at usual antiemetic doses.
Indications / reported uses
  • Symptomatic treatment of nausea and vomiting with oral or rectal formulations where metopimazine is authorised.

Sources: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11140 · https://www.ncbi.nlm.nih.gov/mesh/?term=metopimazine

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Metopimazine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Metopimazine Permitted Daily Exposure (PDE) report (the Metopimazine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Metopimazine Occupational Exposure Limit (OEL) report (the Metopimazine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.